申请人:Hoffmann-La Roche Inc.
公开号:US05830920A1
公开(公告)日:1998-11-03
Compounds of the formula ##STR1## wherein n.sup.1 -n.sup.9 are each independently 0 or 1; m.sup.1 -m.sup.9 are each independently 0 or 1, but with the proviso that at least one of m.sup.1, m.sup.2 and m.sup.3, at least one of m.sup.4, m.sup.5 and m.sup.6 and, when present, at least one of m.sup.7, m.sup.8 and m.sup.9 is 1; and wherein X.sup.1 -X.sup.18 each independently is --O--, --CONR.sup.1,--NR.sup.1 CO-- or --NR.sup.1 --; R.sup.1 is hydrogen or lower alkyl; W is a benzene or s-triazine; Y.sup.1 -Y.sup.9 each independently is an aromatic ring systems; A.sup.1 -A.sup.3 each independently is a residue of a sugar alcohol devoid of the 1-hydroxy group or a derivative thereof, a residue of a sugar acid devoid of the 1-carboxy group or a derivative thereof or tris-(hydroxymethyl)-methyl; D is the di-residue of a sugar alcohol devoid of 2 hydroxy groups or a derivative thereof or the di-residue of a sugar dicarboxylic acid devoid of 2 carboxy group or a derivative thereof; Q.sup.1 -Q.sup.3 and Z.sup.1 -Z3 each independently are the di-residue of a sugar alcohol devoid of 2 hydroxy groups or a derivative thereof or the di-residue of a sugar dicarboxylic acid devoid of 2 carboxy groups or a derivative thereof or didesoxyglycopyranoside or a derivative thereof, wherein at least one hydroxy group of residues A.sup.1 -A.sup.3, D, Q.sup.1 -Q.sup.3 and Z.sup.1 -Z.sup.3 is esterified with sulfuric acid, and pharmaceutically usable salts thereof are useful for the treatment of disorders which are characterized by excessive or destructive proliferation of smooth muscle cells.
式##STR1##中,n.sup.1 -n.sup.9分别独立地为0或1;m.sup.1 -m.sup.9分别独立地为0或1,但至少其中一个m.sup.1,m.sup.2和m.sup.3中的至少一个,m.sup.4,m.sup.5和m.sup.6中的至少一个以及(存在时)m.sup.7,m.sup.8和m.sup.9中的至少一个为1;其中X.sup.1 -X.sup.18分别独立地为--O--,--CONR.sup.1,--NR.sup.1 CO--或--NR.sup.1--;R.sup.1为氢或较低的烷基;W为苯或s-三嗪;Y.sup.1 -Y.sup.9分别独立地为芳香环系统;A.sup.1 -A.sup.3分别独立地为不含1-羟基的糖醇残基或其衍生物,不含1-羧基的糖酸残基或其衍生物或三-(羟甲基)-甲基;D为不含2个羟基的糖醇的二残基或其衍生物或不含2个羧基的糖二羧酸的二残基或其衍生物;Q.sup.1 -Q.sup.3和Z.sup.1 -Z3分别独立地为不含2个羟基的糖醇的二残基或其衍生物或不含2个羧基的糖二羧酸的二残基或其衍生物或二脱氧基葡萄糖苷或其衍生物,其中残基A.sup.1 -A.sup.3,D,Q.sup.1 -Q.sup.3和Z.sup.1 -Z.sup.3中至少一个羟基与硫酸酯化,以及其药用可用盐对于治疗以平滑肌细胞过度或破坏性增殖为特征的疾病是有用的。